Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs

Smith, Cory, Gore, Athurva, Yan, Wei, Abalde-Atristain, Leire, Li, Zhe, He, Chaoxia, Wang, Ying, Brodsky, Robert A. +3 more·2014·Cell stem cell

DOI 10.1016/j.stem.2014.06.011

Cited by (339)

Items 201–300 of 339

Eliminate mitochondrial diseases by gene editing in germ-line cells and embryos
Si Wang, Fei Yi, Jing Tao Qu · 2015 · Protein & Cell
CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish
Federico Gonzãlez · 2016 · Developmental Dynamics
Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
A. Hotta · 2015 · Journal of Neuromuscular Diseases
Noncoding loci without epigenomic signals can be essential for maintaining global chromatin organization and cell viability
Bo Ding, Ying Liu, Zhiheng Liu, Lina Zheng, Ping Xu, Chen Zhao, Peiyao Wu, Ying Zhao, Qian Pan, Yu Guo et al. · 2021 · Science Advances
Doxycycline inducible overexpression systems: how to induce your gene of interest without inducing misinterpretations
Jolan De Boeck, Catherine M. Verfaillie · 2021 · Molecular Biology of the Cell
Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases
Abidemi A. Adegbola, Luke A. D. Bury, Chen Sheng Fu, Meixiang Zhang, Anthony J. Wynshaw-Boris · 2017 · Stem Cells Translational Medicine
DAJIN enables multiplex genotyping to simultaneously validate intended and unintended target genome editing outcomes
Akihiro Kuno, Yoshihisa Ikeda, Shinya Ayabe, Kanako Kato, Kotaro Sakamoto, Sayaka Suzuki, Kento Morimoto, Arata Wakimoto, Natsuki Mikami, Miyuki Ishida et al. · 2022 · PLoS Biology
Comprehensive analysis of off-target and on-target effects resulting from liver-directed CRISPR-Cas9-mediated gene targeting with AAV vectors
Kshitiz Singh, Raffaele Fronza, Hanneke Evens, Marinee Chuah, Thierry VandenDriessche · 2024 · Molecular Therapy — Methods & Clinical Development
The Application of CRISPR-Cas9 Genome Editing in Caenorhabditis elegans
Suhong Xu · 2015 · Journal of genetics and genomics/Journal of Genetics and Genomics
CRISPR/Cas9 Edited Induced Pluripotent Stem Cell-Based Vascular Tissues to Model Aging and Disease-Dependent Impairment
Aylin Acun, Pınar Zorlutuna · 2019 · Tissue Engineering Part A
HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells
Yoo‐Wook Kwon, Hyo-Suk Ahn, Jin Woo Lee, Han‐Mo Yang, Hyun‐Jai Cho, Seok Joong Kim, Shin-Hyae Lee, Heung-Mo Yang, Hyun-Duk Jang, Sung Joo Kim et al. · 2021 · Stem Cells International
Genome-wide detection and analysis of CRISPR-Cas off-targets
Tomás Rodríguez, Sina Dadafarin, Henry Pratt, Pengpeng Liu, Nadia Amrani, Lihua Julie Zhu · 2021 · Progress in molecular biology and translational science
Manipulating and studying gene function in human pluripotent stem cell models
Elisa Balmas, Federica Sozza, Sveva Bottini, Maria Luisa Ratto, Giulia Savoré, Silvia Becca, Kirsten E Snijders, Alessandro Bertero · 2023 · FEBS Letters
The application of CRISPR technology to high content screening in primary neurons
Ben L. Callif, Brian Maunze, Nick L. Krueger, Matthew T. Simpson, Murray G. Blackmore · 2017 · Molecular and Cellular Neuroscience
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation and modulates translation and splicing
Andrea Stoehr, Leslie Kennedy, Yanqin Yang, Sajni Patel, Yongshun Lin, Kaari L. Linask, Marı́a M. Fergusson, Jun Zhu, Marjan Guček, Jizhong Zou et al. · 2019 · JCI Insight
Regulatory Assessment of Off-Target Changes and Spurious DNA Insertions in Gene-Edited Organisms for Agri-Food Use
Martin Alfredo Lema · 2021 · Journal of Regulatory Science
Low-Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells
Seigo Hatada, Aparna Subramanian, Berhan Mandefro, Songyang Ren, Ho Won Kim, Jie Tang, Vincent Anthony Funari, Robert H. Baloh, Dhruv Sareen, Vaithilingaraja Arumugaswami et al. · 2015 · Stem Cells Translational Medicine
CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo
Xin Xu, Jiangfeng Li, Yi Zhu, Bo Xie, Xiao Wang, Song Wang, Haiyun Xie, Huaqing Yan, Yufan Ying, Yiwei Lin et al. · 2017 · Oncotarget
Salient Features of Endonuclease Platforms for Therapeutic Genome Editing
Michael T. Certo, Richard A. Morgan · 2016 · Molecular Therapy
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Shaina N. Porter, Rachel M. Levine, Shondra M. Pruett‐Miller · 2019 · Comprehensive physiology
Experimental Modeling of Myeloproliferative Neoplasms
Lucie Lanikova, Oľga Babošová, Josef T. Prchal · 2019 · Genes
Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan
Teruhide Yamaguchi, Eriko Uchida, Takashi Okada, Keiya Ozawa, Masafumi Onodera, Akihiro Kume, Takashi Shimada, Satoru Takahashi, Kenzaburo Tani, Yasutomo Nasu et al. · 2020 · Human Gene Therapy
CRISPR-engineered genome editing for the next generation neurological disease modeling
Weijun Feng, Hai‐Kun Liu, Daisuke Kawauchi · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
CRISPR/Cas9; A robust technology for producing genetically engineered plants
Rimsha Farooq, Khadim Hussain, Shahid Nazir, Muhammad Rizwan Javed, Nazish Masood · 2018 · Cellular and Molecular Biology
A calibrated cell‐based functional assay to aid classification of MLH1 DNA mismatch repair gene variants
Abhijit Rath, Alexander A. Radecki, Kaussar Rahman, Rachel B. Gilmore, Jonathan R. Hudson, Matthew Cenci, Sean V. Tavtigian, James P. Grady, Christopher D. Heinen · 2022 · Human Mutation
Efficient and Specific Generation of MSTN-Edited Hu Sheep Using C-CRISPR
Rihong Guo, Huili Wang, Chunhua Meng, Hongbing Gui, Yinxia Li, Fang Chen, Chenjian Zhang, Han Zhang, Qiang Ding, Jianli Zhang et al. · 2023 · Genes
Induction of local immunosuppression in allogeneic cell transplantation by cell-type-specific expression of PD-L1 and CTLA4Ig
Wenliang Zhu, Mengqi Li, Jun Zou, Da Zhang, Minghui Fang, Yun Sun, Can Li, Mingming Tang, Yu–Kai Wang, Qi Zhou et al. · 2023 · Stem Cell Reports
TALEN‐mediated gene editing of the thrombospondin‐1 locus in axolotl
Tzu‐Hsing Kuo, Johanna E. Kowalko, Tia DiTommaso, Mandi Nyambi, Daniel T. Montoro, Jeffrey J. Essner, Jessica L. Whited · 2015 · Regeneration
Regenerative medicine: targeted genome editing in vivo
Lixia Wang, Jun Wu, Weiwei Fang, Guang‐Hui Liu, Juan Carlos Izpisúa Belmonte · 2015 · Cell Research
Conditional gene knockout and reconstitution in human iPSCs with an inducible Cas9 system
Mengyao Wu, Senquan Liu, Yongxing Gao, Hao Bai, Vasiliki Machairaki, Gang Li, Tong Chen, Linzhao Cheng · 2018 · Stem Cell Research
Engineered iPSC ‐derived natural killer cells: recent innovations in translational innate anti‐cancer immunotherapy
Jane Q. J. Sun, Melissa R. Elliott, Fernando Souza-Fonseca-Guimarães · 2025 · Clinical & Translational Immunology
All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells
Tetsushi Sakuma, Takuya Sakamoto, Takashi Yamamoto · 2016 · Methods in molecular biology
Characterizing genes associated with cancer using the CRISPR/Cas9 system: A systematic review of genes and methodological approaches
Fernando Gonzalez-Salinas, Claudia Martínez-Amador, Víctor Treviño · 2022 · Gene
The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
Fuga Takahashi, Praneel Patel, Takahiro Kitsuka, Kenichi Arai · 2023 · Bioengineering
The experimental design and data interpretation in “Unexpected mutations after CRISPR–Cas9 editing in vivo ” by Schaefer et al. are insufficient to support the conclusions drawn by the authors
Christopher J. Wilson, Tim J. Fennell, Anne Bothmer, Morgan L. Maeder, Deepak Reyon, Cecilia Cotta‐Ramusino, Cecilia A. Fernández, Eugenio Marco, Luis Alberto Barrera, Hariharan Jayaram et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology
Nicola L. Beer, Anna L. Gloyn · 2016 · F1000Research
Toward a CRISPR Picture: Use of CRISPR/Cas9 to Model Diseases in Human Stem Cells In Vitro
Jamie L. Freiermuth, Ian J. Powell‐Castilla, G. Ian Gallicano · 2017 · Journal of Cellular Biochemistry
Genome Editing in Human Pluripotent Stem Cells
Cory J. Smith, Zhaohui Ye, Linzhao Cheng · 2016 · Cold Spring Harbor Protocols
CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells
Xianglian Ge, Haitao Xi, Fayu Yang, Xiao Zhi, Yanghua Fu, Ding Chen, Ren‐He Xu, Ge Lin, Jia Qu, Junzhao Zhao et al. · 2016 · Molecular Therapy — Nucleic Acids
CRISPR/Cas9: The Leading Edge of Genome Editing Technology
Tetsushi Sakuma, Takashi Yamamoto · 2014 · Springer eBooks
Genome editing: applications for medicinal and aromatic plants
Summia Rehman, Ishfaq Ul Rehman, Bushra Jan, Irfan Rashid, Zafar A. Reshi, Aijaz Hassan Ganie · 2020 · Elsevier eBooks
Whole Genome Sequencing Analysis of Effects of CRISPR/Cas9 in Komagataella phaffii: A Budding Yeast in Distress
Veronika Schusterbauer, Jasmin Elgin Fischer, Sarah Gangl, Lisa Schenzle, Claudia Rinnofner, Martina Geier, Christian Sailer, Anton Glieder, Gerhard Thallinger · 2022 · Journal of Fungi
CRISPR-Cas9 System as a Genome Editing Tool in Sugarcane
Sruthy Maria Augustine · 2017 · Springer eBooks
Genome Editing Redefines Precision Medicine in the Cardiovascular Field
Elda Dzilic, Harald Lahm, Martina Dreßen, Marcus-André Deutsch, Rüdiger Lange, Sean M. Wu, Markus Krane, Stefanie A. Doppler · 2018 · Stem Cells International
Reprogramming of somatic cells
Vania Broccoli · 2017 · Progress in brain research
CRISPR-Cas systems for genome editing of mammalian cells
Indra Mani, Takayuki Arazoe, Vijai Singh · 2021 · Progress in molecular biology and translational science
Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
Marianna Tsifaki, Sophia Kelaini, Rachel Caines, Chunbo Yang, Andriana Margariti · 2018 · Frontiers in Cardiovascular Medicine
Tracking CRISPR’s Footprints
Lin Lin, Yonglun Luo · 2019 · Methods in molecular biology
Convergence of human pluripotent stem cell, organoid, and genome editing technologies
Lin Wang, Zhaohui Ye, Yoon-Young Jang · 2021 · Experimental Biology and Medicine
Precision genome-editing with CRISPR/Cas9 in human induced pluripotent stem cells
John Budde, Rita J. Martinez, Simon Hsu, Natalie Wen, Jason Chen, Giovanni Coppola, Alison Goate, Carlos Cruchaga, Celeste M M. Karch · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes
Lorraine Soares De Oliveira, J. Kaserman, A. H. van der Spek, Nora J. Lee, Hendrik J Undeutsch, R. Werder, Andrew A. Wilson, Anthony N. Hollenberg · 2024 · Molecular Metabolism
Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells
Kaivalya Molugu, Namita Khajanchi, Cícera Regina Lazzarotto, Shengdar Q. Tsai, Krishanu Saha · 2023 · The CRISPR Journal
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases
Amir Gholamzad, Hadis Sadeghi, Maryam Azizabadi Farahani, Ali Faraji, Mahya Rostami, Sajad Khonche, Shirin Kamrani, Mahsa Khatibi, Omid Moeini, SeyedArmit Hosseini et al. · 2023 · Neurology Letters
The therapeutic potential of genome editing for β-thalassemia
Astrid Glaser, Bradley McColl, Jim Vadolas · 2015 · F1000Research
Impairment of the transition from proliferative stage to prehypertrophic stage in chondrogenic differentiation of human induced pluripotent stem cells harboring the causative mutation of achondroplasia in fibroblast growth factor receptor 3
Naohiro Horie, Atsuhiko Hikita, Satoru Nishizawa, Sakura Uto, Tsuyoshi Takato, Kazuto Hoshi · 2017 · Regenerative Therapy
An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing
Nannan Duan, Shuqing Tang, Baitao Zeng, Zhiqing Hu, Qian Hu, Lingqian Wu, Miaojin Zhou, Desheng Liang · 2021 · Life
DGK and DZHK position paper on genome editing: basic science applications and future perspective
Ralf Peter Brandes, Anne Dueck, Stefan Hanns Engelhardt, Manuel Kaulich, Christian Kupatt, Maria Teresa De Angelis, Matthias S. Leisegang, Ferdinand A. C. le Noble, Alessandra Moretti, Oliver Josef Müller et al. · 2021 · Basic Research in Cardiology
Recent advances in therapeutic recruitment of mammalian RNAi and bacterial CRISPR-Cas DNA interference pathways as emerging antiviral strategies
Wei-Xin Chin, Swee Kim Ang, Justin Jang Hann Chu · 2016 · Drug Discovery Today
Genome Editing in Mice Using CRISPR/Cas9: Achievements and Prospects
Fabien Delerue · 2015 · Cloning & Transgenesis
CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium
Chew-Li Soh, Danwei Huangfu · 2016 · Methods in molecular biology
Whole-Genome Sequencing Reveals Rare Off-Target Mutations in MC1R -Edited Pigs Generated by Using CRISPR-Cas9 and Somatic Cell Nuclear Transfer
Zhenyang Li, Jin Lan, Xuan Shi, Tong Lu, Xiaoli Hu, Xiaohong Liu, Yaosheng Chen, Zuyong He · 2024 · The CRISPR Journal
Novel off-Targeting Events Identified after Genome Wide Analysis of CRISPR-Cas Edited Pigs
Bethany K. Redel, Junchul David Yoon, Emily D. Reese, Hong An, Kyungjun Uh, Paula R. Chen, Randall S. Prather, Kiho Lee · 2024 · The CRISPR Journal
CRISPR/Cas9 and TALE: beyond cut and paste
Liping Deng, Ruotong Ren, Jun Wu, Keiichiro Suzuki, Juan Carlos Izpisúa Belmonte, Guang‐Hui Liu · 2015 · Protein & Cell
The genome editing revolution: A CRISPR-Cas TALE off-target story
Stefano Stella, Guillermo Montoya · 2015 · Inside the Cell
Applications of Genome Editing Techniques for the Improvement of Medicinal Plants
Reema Mishra, Preeti Agarwal, Aparajita Mohanty · 2022 · Springer eBooks
Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease
Haojie Yu, Chad A. Cowan · 2016 · Molecular Endocrinology
iPSCs-Derived Neurons and Brain Organoids from Patients
Wanying Zhu, Lei Xu, Xinrui Li, Hao Hu, Shu-Ning Lou, Yan Liu · 2023 · Handbook of experimental pharmacology
Beyond precision: evaluation of off-target clustered regularly interspaced short palindromic repeats/Cas9–mediated genome editing
Irene Peña-Gutiérrez, Beatriz Olalla-Sastre, Paula Rı́o, Juan R. Rodríguez-Madoz · 2024 · Cytotherapy
Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases
Samantha Nicholson · 2015 · World Journal of Hepatology
Regulatory elements can be essential for maintaining broad chromatin organization and cell viability
Ying Liu, Bo Ding, Lina Zheng, Ping Xu, Zhiheng Liu, Zhao Chen, Peiyao Wu, Ying Zhao, Qian Pan, Yu Guo et al. · 2022 · Nucleic Acids Research
CRISPR system for genome engineering: the application for autophagy study
Jianzhou Cui, Shirley Jia Li Chew, Yin Pu Shi, Zhiyuan Gong, Han‐Ming Shen · 2017 · BMB Reports
Therapeutic Gene Editing with CRISPR
Elan Hahn, Matthew Hiemenz · 2020 · Clinics in Laboratory Medicine
Induced Pluripotent Stem Cells in Regenerative Medicine
Luna Simona Pane, Ilaria My, Alessandra Moretti · 2016 · Springer eBooks
Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva
Emilie Barruet, Edward Chiaming Hsiao · 2017 · Bone
Precision Genome Editing for Smarter, Inclusive, and Nutritious Crops: Emerging Tools, Omics Integration, and Global Perspectives
2026 · Trends in Animal and Plant Sciences
Genome Editing with Targetable Nucleases
S. William Pelletier · 2016 · Springer eBooks
Mechanistic Insights and Therapeutic Potential of Small Nucleolar RNA Host Genes in the Carcinogenesis of Hepatocellular Carcinoma
Jiajia Luo, Zhang‐Xiu Liao, Shuangxia Zhang · 2025 · Cancer Medicine
HMGB1 regulates mitochondrial structure and reactive oxygen species balance during the transition from naïve to primed pluripotency
Tatiana Yu. Starkova, Sergey V. Ponomartsev, Veniamin Fishman, Нариман Рашитович Баттулин, Nikolay Aksenov, Evgeny I. Bakhmet, Andrey A. Kuzmin, Dmitry S. Bogolyubov, Sergey A. Sinenko, Alexey N. Tomilin · 2026 · Frontiers in Cell and Developmental Biology
CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
Muhammad Abid Sheikh, Farah Afandi, Grazia Iannello, Barbara Corneo, Bright Starling Emerald, Suraiya Anjum Ansari · 2024 · Journal of Visualized Experiments
Mechanism of LncRNA-MiRNA in Renal Intrinsic Cells of Diabetic Kidney Disease and Potential Therapeutic Direction
Xiyue Tian, Min Zhou, Jingbo Zhang, Xinchun Huang, Dongyang Jiang, Jian Liu, Qiong Zhang, Dingguo Chen, Qiongdan Hu · 2025 · DNA and Cell Biology
Off-target effects in genome editing
Igor Kovalchuk · 2021 · Elsevier eBooks
The caveats and setbacks of mouse genome editing tools in biomedical studies
Athena Hsu Li, Shi‐Bing Yang · 2023 · Gene Reports
The Challenge of a “Functional Cure” for AIDS by Gene Modified HSCT Therapy
Lei Xu, Hu Chen, Bin Zhang · 2015 · Current Stem Cell Research & Therapy
At the Conflux of Human Genome Engineering and Induced Pluripotency
Knut Woltjen, Fabian Oceguera-Yañez, Harunobu Kagawa, Shin‐Il Kim · 2016 · Springer eBooks
Application of CRISPR/Cas9 system for developing and studying cellular models of inherited disease
Kamila R. Valetdinova · 2016 · Genes and Cells
From bench to bedside: stem cell therapy as a transformative approach against HIV
Ankit Kumar Bharti S, Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan, Babu Gajendran, Rahul Vashishth, Sabina Evan Prince · 2026 · Molecular Biology Reports
Variations on a Theme: Crispr Models for 15q11-Q13 Disorders and Beyond
Barbara J. Bailus · 2014 · Brain Disorders & Therapy
Modeling rare pediatric neurogenetic disorders with IPSCs
Jaemin Kim, David Nonis, María Gabriela Otero, Tyler Mark Pierson · 2019 · AIMS Cell and Tissue Engineering
Combining Off‐flow, a Nextflow‐coded program, and whole genome sequencing reveals unintended genetic variation in CRISPR/Cas-edited iPSCs
Carole Shum, Sang Yeon Han, Bhooma Thiruvahindrapuram, Zhuozhi Wang, Jill de Rijke, Benjamin Zhang, Maria Sundberg, Ci-Di Chen, Elizabeth D. Buttermore, Nina R. Makhortova et al. · 2023 · Computational and Structural Biotechnology Journal
OUP accepted manuscript
Selma Souf · 2016 · Bioscience Horizons The International Journal of Student Research
Gene Editing in Regenerative Medicine
Yunlan Fang, Xuguang Chen, W.T. Godbey · 2018 · Elsevier eBooks
Genome editing of a hybridoma cell line via the CRISPR/Cas9 system: A new approach for constitutive high-level expression of heterologous proteins in eukaryotic system
Nicoletta Schibeci Natoli Scialli, Barbara Colitti, Luigi Bertolotti, Giulia Pezzoni, Eugenio Martignani, Maverick Melega, Emiliana Brocchi, Sergio Rosati · 2021 · Veterinary Immunology and Immunopathology
PEAR1 is a potential regulator of early hematopoiesis of human pluripotent stem cells
Shuo Zhang, Kengyuan Qu, Shuzhen Lyu, Dixie L. Hoyle, Cory J. Smith, Linzhao Cheng, Tao Cheng, Jun Shen, Z Wang · 2022 · Journal of Cellular Physiology
Using CRISPR-Cas9 Genome Editing to Enhance Cell Based Therapies for the Treatment of Diabetes Mellitus
Nicole A. J. Krentz, Francis C. Lynn · 2016 · Springer eBooks
MOLECULAR AND BIOCHEMICAL DIAGNOSIS OF LOCAL ISOLATES OF STREPTOMYCES SPECIES FROM SOILS OF IRAQ
Hana Fawzi Hussien, Safaa Ismail Al-Obaidi · 2021 · PLANT ARCHIVES
Reengineering of the CRISPR/Cas System
Zulqurnain Khan, Tahmina Sattar, Maria Siddique, Zulfiqar Ali, Asif Ali Khan, Syed Ovais Aftab, Muhammad Zubair Ghouri, Qaisar Sultan, Nauman Gulzar, Farooq Ahmad · 2022 · Springer eBooks
Severe perinatal hydrops fetalis in genome edited pigs with a biallelic five base pair deletion of the Marfan syndrome gene, FBN1
Hiu‐Gwen Tsang, Simon Geoffrey Lillico, Christopher Proudfoot, Mary E. B. McCulloch, Greg Robert Markby, Violeta Trejo-Reveles, BRENDAN M. CORCORAN, Bruce Whitelaw, Vicky Elizabeth MacRae, KIM M. SUMMERS · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Specificity of CRISPR‐Cas9 Gene Editing
Niklas Selfjord, Alexandra Madsen, Pınar Akçakaya · 2022 · Wiley eBooks
Progress in HIV-1 Prevention, Control and Treatment: Genetic Manipulation or Pharmacological Blockade of Chemokine Receptor 5?
Abdullahi İbrahim Uba, Gonca Dilcan, Sani Sharif Usman · 2016 · Journal of Advances in Biology & Biotechnology
Analytical dissection of CRISPR-Cas9-mediated gene editing fidelity: integrating next-generation bioanalytical platforms for precision immunotherapeutics and rare disease correction
A. M. Mukherjee · 2026 · Journal of Rare Diseases